
### [NCIT:C3771](http://purl.obolibrary.org/obo/NCIT_C3771)
**Label:** Lobular Breast Carcinoma

**Subclasses:** [NCIT:C4018](http://purl.obolibrary.org/obo/NCIT_C4018) (Lobular Breast Carcinoma In Situ), [NCIT:C97049](http://purl.obolibrary.org/obo/NCIT_C97049) (Invasive Lobular Breast Carcinoma, Alveolar Variant), [NCIT:C54691](http://purl.obolibrary.org/obo/NCIT_C54691) (Invasive Lobular Breast Carcinoma, Signet Ring Variant), [NCIT:C76328](http://purl.obolibrary.org/obo/NCIT_C76328) (Metastatic Lobular Breast Carcinoma), [NCIT:C7950](http://purl.obolibrary.org/obo/NCIT_C7950) (Invasive Lobular Breast Carcinoma), [NCIT:C97051](http://purl.obolibrary.org/obo/NCIT_C97051) (Invasive Lobular Breast Carcinoma, Pleomorphic Variant), [NCIT:C97052](http://purl.obolibrary.org/obo/NCIT_C97052) (Invasive Lobular Breast Carcinoma, Solid Variant), [NCIT:C137839](http://purl.obolibrary.org/obo/NCIT_C137839) (Pleomorphic Lobular Breast Carcinoma In Situ), [NCIT:C97053](http://purl.obolibrary.org/obo/NCIT_C97053) (Invasive Lobular Breast Carcinoma, Tubulolobular Variant), 

**Class expressions from DL-Learner:**

- Thing 53.35%
- [NCIT:C40557](http://purl.obolibrary.org/obo/NCIT_C40557) (Metastatic Lesion) 52.94%
- [NCIT:C38721](http://purl.obolibrary.org/obo/NCIT_C38721) (Nuclear Pleomorphism) 52.94%
- [NCIT:C36182](http://purl.obolibrary.org/obo/NCIT_C36182) (Solid Growth Pattern) 52.94%
- [NCIT:C36177](http://purl.obolibrary.org/obo/NCIT_C36177) (Single-File Linear Pattern) 52.94%
- [NCIT:C36131](http://purl.obolibrary.org/obo/NCIT_C36131) (Moderately Differentiated Lesion) 52.94%
- [NCIT:C36130](http://purl.obolibrary.org/obo/NCIT_C36130) (Low Grade Lesion) 52.94%
- [NCIT:C61294](http://purl.obolibrary.org/obo/NCIT_C61294) (Tubular Structures Present) 38.30%
- [NCIT:C61294](http://purl.obolibrary.org/obo/NCIT_C61294) (Tubular Structures Present) and (not ([NCIT:C39907](http://purl.obolibrary.org/obo/NCIT_C39907) (Seminal Vesicle Cystadenoma))) 38.30%
- [NCIT:C61294](http://purl.obolibrary.org/obo/NCIT_C61294) (Tubular Structures Present) and (not ([NCIT:C39906](http://purl.obolibrary.org/obo/NCIT_C39906) (Seminal Vesicle Adenocarcinoma))) 38.30%
- [NCIT:C61294](http://purl.obolibrary.org/obo/NCIT_C61294) (Tubular Structures Present) and (not ([NCIT:C39905](http://purl.obolibrary.org/obo/NCIT_C39905) (Prostate Stromal Proliferation of Uncertain Malignant Potential))) 38.30%
- [NCIT:C61294](http://purl.obolibrary.org/obo/NCIT_C61294) (Tubular Structures Present) and (not ([NCIT:C39903](http://purl.obolibrary.org/obo/NCIT_C39903) (Prostate Adenocarcinoma with Focal Neuroendocrine Differentiation))) 38.30%
- [NCIT:C61294](http://purl.obolibrary.org/obo/NCIT_C61294) (Tubular Structures Present) and (not ([NCIT:C39902](http://purl.obolibrary.org/obo/NCIT_C39902) (Prostate Basal Cell Carcinoma))) 38.30%
- [NCIT:C61294](http://purl.obolibrary.org/obo/NCIT_C61294) (Tubular Structures Present) and (not ([NCIT:C39901](http://purl.obolibrary.org/obo/NCIT_C39901) (Prostatic Duct Urothelial Carcinoma))) 38.30%
- [NCIT:C61294](http://purl.obolibrary.org/obo/NCIT_C61294) (Tubular Structures Present) and (not ([NCIT:C39899](http://purl.obolibrary.org/obo/NCIT_C39899) (Secondary Prostate Urothelial Carcinoma))) 38.30%


